Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.318 EUR | +2.33% |
|
+5.10% | +2.33% |
06-14 | Abionyx: positive response from FDA, share price rises | CF |
06-13 | ABIONYX Pharma Completes Pre-IND Meeting with the FDA for CER-001 Phase 2b/3 Clinical Trial for Patients with Sepsis | CI |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+2.33% | 44.55M | |
+15.81% | 121B | |
+18.56% | 112B | |
+4.43% | 22.57B | |
-18.23% | 20.82B | |
-13.60% | 16.3B | |
-16.61% | 16.19B | |
-43.53% | 16.17B | |
+2.11% | 13.17B | |
+25.99% | 11.11B |
- Stock Market
- Equities
- ABNX Stock
- News ABIONYX Pharma
- Cerenis Therapeutics Announces Appointment of Barbara Yanni to Board of Directors